These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36627197)

  • 81. BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer.
    Weber-Lassalle N; Hauke J; Ramser J; Richters L; Groß E; Blümcke B; Gehrig A; Kahlert AK; Müller CR; Hackmann K; Honisch E; Weber-Lassalle K; Niederacher D; Borde J; Thiele H; Ernst C; Altmüller J; Neidhardt G; Nürnberg P; Klaschik K; Schroeder C; Platzer K; Volk AE; Wang-Gohrke S; Just W; Auber B; Kubisch C; Schmidt G; Horvath J; Wappenschmidt B; Engel C; Arnold N; Dworniczak B; Rhiem K; Meindl A; Schmutzler RK; Hahnen E
    Breast Cancer Res; 2018 Jan; 20(1):7. PubMed ID: 29368626
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Evaluation of pathogenetic mutations in breast cancer predisposition genes in population-based studies conducted among Chinese women.
    Zeng C; Guo X; Wen W; Shi J; Long J; Cai Q; Shu XO; Xiang Y; Zheng W
    Breast Cancer Res Treat; 2020 Jun; 181(2):465-473. PubMed ID: 32318955
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia.
    Ben Ayed-Guerfali D; Ben Kridis-Rejab W; Ammous-Boukhris N; Ayadi W; Charfi S; Khanfir A; Sellami-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    J Transl Med; 2021 Mar; 19(1):108. PubMed ID: 33726785
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy.
    Ghiorzo P; Pensotti V; Fornarini G; Sciallero S; Battistuzzi L; Belli F; Bonelli L; Borgonovo G; Bruno W; Gozza A; Gargiulo S; Mastracci L; Nasti S; Palmieri G; Papadia F; Pastorino L; Russo A; Savarino V; Varesco L; Bernard L; Bianchi Scarrà G;
    Fam Cancer; 2012 Mar; 11(1):41-7. PubMed ID: 21989927
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer.
    Oda K; Aoki D; Tsuda H; Nishihara H; Aoyama H; Inomata H; Shimada M; Enomoto T
    Cancer Sci; 2023 Jan; 114(1):271-280. PubMed ID: 36254756
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Targeted sequencing of BRCA1 and BRCA2 across a large unselected breast cancer cohort suggests that one-third of mutations are somatic.
    Winter C; Nilsson MP; Olsson E; George AM; Chen Y; Kvist A; Törngren T; Vallon-Christersson J; Hegardt C; Häkkinen J; Jönsson G; Grabau D; Malmberg M; Kristoffersson U; Rehn M; Gruvberger-Saal SK; Larsson C; Borg Å; Loman N; Saal LH
    Ann Oncol; 2016 Aug; 27(8):1532-8. PubMed ID: 27194814
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Inherited Mutations in Women With Ovarian Carcinoma.
    Norquist BM; Harrell MI; Brady MF; Walsh T; Lee MK; Gulsuner S; Bernards SS; Casadei S; Yi Q; Burger RA; Chan JK; Davidson SA; Mannel RS; DiSilvestro PA; Lankes HA; Ramirez NC; King MC; Swisher EM; Birrer MJ
    JAMA Oncol; 2016 Apr; 2(4):482-90. PubMed ID: 26720728
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Evaluation of germline BRCA1 and BRCA2 mutations in a multi-ethnic Asian cohort of ovarian cancer patients.
    Hasmad HN; Lai KN; Wen WX; Park DJ; Nguyen-Dumont T; Kang PCE; Thirthagiri E; Ma'som M; Lim BK; Southey M; Woo YL; Teo SH
    Gynecol Oncol; 2016 May; 141(2):318-322. PubMed ID: 26541979
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Comparison of PARPi efficacy according to homologous recombination deficiency biomarkers in patients with ovarian cancer: a systematic review and meta-analysis.
    Batalini F; DaSilva LL; Campoverde L; Comini ACM; Carvalho BM; Nogueira W; Silveira H; Ernst BJ; Mina LA
    Chin Clin Oncol; 2023 Jun; 12(3):21. PubMed ID: 37211773
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The clinical importance of BRCAness in a population-based cohort of Danish epithelial ovarian cancer.
    Hjortkjær M; Malik Aagaard Jørgensen M; Waldstrøm M; Ørnskov D; Søgaard-Andersen E; Jakobsen A; Dahl-Steffensen K
    Int J Gynecol Cancer; 2019 Jan; 29(1):166-173. PubMed ID: 30640700
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.
    Abdel-Rahman MH; Sample KM; Pilarski R; Walsh T; Grosel T; Kinnamon D; Boru G; Massengill JB; Schoenfield L; Kelly B; Gordon D; Johansson P; DeBenedictis MJ; Singh A; Casadei S; Davidorf FH; White P; Stacey AW; Scarth J; Fewings E; Tischkowitz M; King MC; Hayward NK; Cebulla CM
    Ophthalmology; 2020 May; 127(5):668-678. PubMed ID: 32081490
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Pathogenic Variants in Adult-Onset Cancer Predisposition Genes in Pediatric Cancer: Prevalence and Impact on Tumor Molecular Features and Clinical Management.
    McGee RB; Oak N; Harrison L; Xu K; Nuccio R; Blake AK; Mostafavi R; Lewis S; Taylor LM; Kubal M; Ouma A; Hines-Dowell SJ; Cheng C; Furtado LV; Nichols KE
    Clin Cancer Res; 2023 Apr; 29(7):1243-1251. PubMed ID: 36693186
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Somatic mutations that affect early genetic progression and immune microenvironment in gastric carcinoma.
    Li X; Tang Z; Li Z; Li Z; Zhao P; Song Y; Yang K; Xia Z; Wang Y; Guo D
    Pathol Res Pract; 2024 May; 257():155310. PubMed ID: 38663178
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency Testing.
    Rezqallah A; Torres-Esquius S; Llop-Guevara A; Cruellas M; Martinez MT; Romey M; Denkert C; Serra V; Chirivella I; Balmaña J
    JCO Precis Oncol; 2024 Mar; 8():e2300446. PubMed ID: 38513169
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Race-Specific Genetic Profiles of Homologous Recombination Deficiency in Multiple Cancers.
    Hsiao YW; Lu TP
    J Pers Med; 2021 Dec; 11(12):. PubMed ID: 34945758
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Challenges of diagnosing homologous recombination deficiencies in metastatic prostate cancer: a six-year experience from a single institution.
    Gavira J; Tapia JC; Romano A; Anguera G; Aguado M; Piedra A; Bosma F; Sánchez S; Martin C; Algaba F; Arce Y; Ramón Y Cajal T; Maroto P
    Clin Transl Oncol; 2024 Oct; 26(10):2749-2753. PubMed ID: 38722534
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Clinical, Molecular and Genetic Characteristics of Early Onset Gastric Cancer: Analysis of a Large Multicenter Study.
    Pocurull A; Herrera-Pariente C; Carballal S; Llach J; Sánchez A; Carot L; Botargues JM; Cuatrecasas M; Ocaña T; Balaguer F; Bujanda L; Moreira L
    Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34201547
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Case report: A germline
    Qian J; Peng M; Li Y; Liu W; Zou X; Chen H; Zhou S; Xiao S; Zhou J
    Front Oncol; 2024; 14():1380093. PubMed ID: 38686193
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Genotype-phenotype correlations and clinical outcomes of patients with von Hippel-Lindau disease with large deletions.
    Zhang K; Yang W; Ma K; Qiu J; Li L; Xu Y; Zhang Z; Yu C; Zhou J; Gong Y; Cai L; Gong K
    J Med Genet; 2023 May; 60(5):477-483. PubMed ID: 37080588
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Parental mosaicism detection and preimplantation genetic testing in families with multiple transmissions of de novo mutations.
    Xu N; Shi W; Cao X; Zhou X; Jin L; Huang HF; Chen S; Xu C
    J Med Genet; 2023 Sep; 60(9):910-917. PubMed ID: 36707240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.